| 今开：23.97 | 昨收：23.81 |
| 最高：24.51 | 最低：23.745 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.136070462E9 |
产业链观察03-15 00:14
#药闻简讯# 美国FDA已批准$Mirum制药(MIRM)$ LIVMARLI（maralixibat）口服溶液用于治疗5岁及以上进行性家族性肝内胆汁淤积症（PFIC）患者的胆汁淤积性瘙痒。查看全文
Mirum(MIRM)01-26 08:15
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001825 Size: 8 KB 网页链接查看全文
Mirum(MIRM)02-06 10:15
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-002756 Size: 4 KB 网页链接查看全文
Mirum(MIRM)03-16 05:15
$Mirum制药(MIRM)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-032289 Act: 34 Size: 15 MB 网页链接查看全文
Mirum(MIRM)03-26 05:45
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009046 Size: 5 KB 网页链接查看全文
Mirum(MIRM)02-14 06:15
$Mirum制药(MIRM)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-021478 Act: 34 Size: 13 KB 网页链接查看全文
Mirum(MIRM)02-06 10:05
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-002754 Size: 5 KB 网页链接查看全文
Mirum(MIRM)01-26 08:15
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001823 Size: 8 KB 网页链接查看全文
Mirum(MIRM)01-26 08:15
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001824 Size: 8 KB 网页链接查看全文
Mirum(MIRM)01-26 08:15
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001822 Size: 8 KB 网页链接查看全文
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009280 Size: 4 KB 网页链接
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009046 Size: 5 KB 网页链接
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008320 Size: 5 KB 网页链接
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008322 Size: 4 KB 网页链接
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008311 Size: 4 KB 网页链接
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008313 Size: 5 KB 网页链接
$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008316 Size: 6 KB 网页链接
$Mirum制药(MIRM)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-069301 Act: 33 Size: 81 KB 网页链接
$Mirum制药(MIRM)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-032289 Act: 34 Size: 15 MB 网页链接
$Mirum制药(MIRM)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001193125-24-050798 Act: 34 Size: 26 KB 网页链接